Se@SiO₂ nanocomposites attenuate doxorubicin-induced cardiotoxicity through combatting oxidative damage

References

• Cao J, Chen Z, Chi J, et al. Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment. Artif Cells Nanomed Biotechnol. 2018 [cited 2018 Feb 6]; [14 p.]. DOI:10.1080/21691401.2018.1436553
   Web of Science ®Google Scholar
• Shabalala S, Muller CJF, Louw J, et al. Polyphenols, autophagy and doxorubicin-induced cardiotoxicity. Life Sci. 2017;180:160–170.
   PubMed Web of Science ®Google Scholar
• Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639–1642.
   PubMed Web of Science ®Google Scholar
• Jones LW, Haykowsky MJ, Swartz JJ, et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50: 1435–1441.
   PubMed Web of Science ®Google Scholar
• Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339:900–905.
   PubMed Web of Science ®Google Scholar
• Singal PK, Siveski-Iliskovic N, Hill M, et al. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J Mol Cell Cardiol. 1995;27:1055–1063.
   PubMed Web of Science ®Google Scholar
• Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest. 1980;65:128–135.
   PubMed Web of Science ®Google Scholar
• Singal PK, Iliskovic N, Li T, et al. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 1997;11:931–936.
   PubMed Web of Science ®Google Scholar
• Iliskovic N, Singal PK. Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol. 1997;150:727–734.
   PubMed Web of Science ®Google Scholar
• Bian Y, Wei G, Chang TM. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties. Artif Cells Nanomed Biotechnol. 2013;41:60–68.
   PubMed Web of Science ®Google Scholar
• Rezaei-Sadabady R, Eidi A, Zarghami N, et al. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes. Artif Cells Nanomed Biotechnol. 2016;44:128–134.
   PubMed Web of Science ®Google Scholar
• Deng G, Niu K, Zhou F, et al. Treatment of steroid-induced osteonecrosis of the femoral head using porous Se@SiO2 nanocomposites to suppress reactive oxygen species. Sci Rep. 2017;7:43914.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Deng G, Ji A, et al. Porous Se@SiO2 nanospheres treated paraquat-induced acute lung injury by resisting oxidative stress. IJN. 2017;12:7143–7152.
   Web of Science ®Google Scholar
• Wang Y, Chen P, Zhao G, et al. Inverse relationship between elemental selenium nanoparticle size and inhibition of cancer cell growth in vitro and in vivo. Food Chem Toxicol. 2015;85:71–77.
   PubMed Web of Science ®Google Scholar
• Liu X, Deng G, Wang Y, et al. A novel and facile synthesis of porous SiO2-coated ultrasmall Se particles as a drug delivery nanoplatform for efficient synergistic treatment of cancer cells. Nanoscale. 2016;8:8536–8541.
   PubMed Web of Science ®Google Scholar
• Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004;91:11–28.
   PubMed Web of Science ®Google Scholar
• Tan L, Jia X, Jiang X, et al. In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance. Biosens Bioelectron. 2009;24:2268–2272.
   PubMed Web of Science ®Google Scholar
• Estevez H, Garcia-Lidon JC, Luque-Garcia JL, et al. Effects of chitosan-stabilized selenium nanoparticles on cell proliferation, apoptosis and cell cycle pattern in HepG2 cells: comparison with other selenospecies. Colloids Surf B Biointerfaces. 2014;122:184–193.
   PubMed Web of Science ®Google Scholar
• Sulaiman GM, Jabir MS, Hameed AH. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity. Artif Cells Nanomed Biotechnol. 2018 [cited 2018 Jan 31]; [13 p.]. DOI:10.1080/21691401.2018.1434661
   PubMed Web of Science ®Google Scholar
• Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev. 2012;41: 2885–2911.
   PubMed Web of Science ®Google Scholar
• Andreadou I, Mikros E, Ioannidis K, et al. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol. 2014;69:4–16.
   PubMed Web of Science ®Google Scholar
• Liu T, Zeng L, Jiang W, et al. Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells. Nanomedicine. 2015;11:947–958.
   PubMed Web of Science ®Google Scholar
• Zheng W, Cao C, Liu Y, et al. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance. Acta Biomater. 2015;11:368–380.
   PubMed Web of Science ®Google Scholar
• Nasrolahi Shirazi A, Tiwari RK, Oh D, et al. Cyclic peptide-selenium nanoparticles as drug transporters. Mol Pharm. 2014;11: 3631–3641.
   PubMed Web of Science ®Google Scholar
• Gao F, Yuan Q, Gao L, et al. Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles. Biomaterials. 2014;35:8854–8866.
   PubMed Web of Science ®Google Scholar
• Liu W, Li X, Wong YS, et al. Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism. ACS Nano. 2012;6:6578–6591.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang J, Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med. 2007;42:1524–1533.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 2008;101:22–31.
   PubMed Web of Science ®Google Scholar
• He Y, Chen S, Liu Z, et al. Toxicity of selenium nanoparticles in male Sprague-Dawley rats at supranutritional and nonlethal levels. Life Sci. 2014;115:44–51.
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24: 1504–1534.
   PubMed Web of Science ®Google Scholar
• Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241.
   PubMed Web of Science ®Google Scholar
• Holben DH, Smith AM. The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc. 1999;99:836–843.
   PubMed Web of Science ®Google Scholar
• Pannu V, Rida PC, Ogden A, et al. Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach. Cell Death Dis. 2012;3:e346.
   PubMed Web of Science ®Google Scholar
• Wang H, Yu X, Su C, et al. Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells. Artif Cells Nanomed Biotechnol. 2018 [cited 2018 Jan 9]; [9 p.]. DOI:10.1080/21691401.2017.1423494
   Web of Science ®Google Scholar